Company Monitoring Page for BeiGene

latest headlines for company on cafepharma

BMS deal weighs on Celgene partners
BioCentury
Thu, 01/3/19 - 11:45 pm
Tags:
M&A, Celgene, Bristol-Myers Squibb, Acceleron, BeiGene
BeiGene bags Asian rights to Zymeworks’ HER2 bispecifics
Fierce Biotech
Tue, 11/27/18 - 11:32 pm
Tags:
BeiGene, Zymeworks, bispecific antibodies, ZW25, ZW49
Wed, 10/24/18 - 11:53 am
Tags:
BeiGene, zanubrutinib
BeiGene Presents Data on it PARP Inhibitor in Combination With Temozolomide in Solid Tumors
CP Wire
Mon, 10/22/18 - 10:43 am
Tags:
BeiGene, pamiparib, solid tumors
Mon, 10/22/18 - 10:01 am
Tags:
BeiGene, pamiparib
Thu, 09/20/18 - 09:47 am
Tags:
BeiGene, tislelizumab
Hong Kong could become biotech listing hub, says BeiGene boss as Chinese drug maker gears up for US$1 billion flotation
South China Morning Post
Mon, 07/30/18 - 11:12 am
Tags:
Hong Kong, BeiGene, China, biotech
BeiGene Proposes $800+ Million Offering
CP Wire
Fri, 07/27/18 - 11:50 am
Tags:
BeiGene, IPOs
Fri, 07/27/18 - 10:37 am
Tags:
BeiGene, IPO
BeiGene Initiates Ph III Trial of PD-1 Inhibitor Tislelizumab + Chemotherapy in Advanced Non-Squamous Non-Small Cell Lung Cancer in China
CP Wire
Wed, 07/25/18 - 03:11 pm
Tags:
BeiGene, Celgene, tislelizumab, China, monoclonal antibodies
Wed, 07/25/18 - 09:49 am
Tags:
BeiGene, tislelizumab, checkpoint inhibitors
Number 7? Celgene partner BeiGene joins the crowd with stellar PD-1/L1 data from a pivotal test
Endpoints
Mon, 07/23/18 - 09:45 am
Tags:
Celgene, BeiGene, tiselizumab, Hodgkin's lymphoma
BeiGene Initiates Phase 3 Trial of Pamiparib as Maintenance Therapy in Patients with Ovarian Cancer
CP Wire
Thu, 05/17/18 - 12:03 pm
Tags:
BeiGene, pamiparib, ovarian cancer, China, clinical trials
Thu, 05/17/18 - 09:53 am
Tags:
BeiGene, pamiparib, ovarian cancer
2 Biotech Stocks Near All-Time Highs: Can They Keep Climbing?
Motley Fool
Mon, 03/19/18 - 11:41 am
Tags:
biotech, BeiGene, China, Celgene, AnaptysBio, ANB020, eczema
Boehringer, BeiGene enter manufacturing pact for PD-1 drug
Biopharma Dive
Thu, 01/11/18 - 11:54 pm
Tags:
Boehringer Ingelheim, BeiGene, tislelizumab, anti-PD-L1, drug manufacturing
Unstoppable growth of Chinese biotechs attracts over $10bn funding
GoinPharma
Mon, 11/27/17 - 09:07 am
Tags:
China, biotech, Zensun, BeiGene, Chi-Med, Zai Lab, WuXi
Prescribed Reading: I/O is the only game in town
BioPharma Dive
Sat, 07/8/17 - 10:02 am
Tags:
immuno-oncology, Celgene, BeiGene, Endo International, Opana ER, Novartis, Orkambi, Vertex Pharmaceuticals, Merck, Bristol-Myers Squibb, Roche, Opdivo, Keytruda, Orencia
Celgene joins the PD-1 checkpoint club, bagging BeiGene drug with $413M down and $1B on the table
Endpoints
Thu, 07/6/17 - 09:33 am
Tags:
Celgene, anti-PD-L1, BeiGene
China's BeiGene banks $97M to get its cancer drugs into the clinic
Fierce Biotech
Wed, 05/13/15 - 11:22 am
Tags:
China, BeiGene

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.